Detalles de la búsqueda
1.
Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy.
Cell
; 186(16): 3333-3349.e27, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37490916
2.
Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1.
Nat Immunol
; 21(2): 178-185, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31959982
3.
Author Correction: Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1.
Nat Immunol
; 21(6): 695, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32123375
4.
Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
Nature
; 577(7791): 561-565, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31942071
5.
Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
Nature
; 580(7801): E1, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32238929
6.
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study.
Support Care Cancer
; 32(5): 281, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598052
7.
Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesicles.
Proteomics
; 23(7-8): e2200039, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36398564
8.
Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients.
Ann Surg Oncol
; 30(4): 2377-2388, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36752970
9.
Combination therapy with immune check point inhibitors and acute kidney injury.
Acta Oncol
; 62(2): 121-125, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36755491
10.
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy.
Acta Oncol
; 62(1): 62-69, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645166
11.
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types.
Cell Mol Life Sci
; 79(4): 204, 2022 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35332383
12.
Clinical advances and ongoing trials on mRNA vaccines for cancer treatment.
Lancet Oncol
; 23(10): e450-e458, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36174631
13.
Clinical value of routine [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanoma.
Int J Cancer
; 150(11): 1870-1878, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35001363
14.
Transcriptomic signatures of tumors undergoing T cell attack.
Cancer Immunol Immunother
; 71(3): 553-563, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34272988
15.
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial.
Cancer Immunol Immunother
; 71(2): 433-444, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34218294
16.
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021.
J Transl Med
; 20(1): 257, 2022 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35672823
17.
Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting.
Acta Oncol
; 61(1): 45-51, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34666597
18.
The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study.
Eur Heart J
; 42(16): 1621-1631, 2021 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33291147
19.
The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro.
Cancer Immunol Immunother
; 70(6): 1771-1776, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33165629
20.
Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition.
Cytotherapy
; 23(8): 724-729, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33933372